Table 2.
Comparison of primary and secondary outcomes between low- and high-TyG groups.
| TyG | ||||
|---|---|---|---|---|
| Overall | Low Group | High Group | p-Value * | |
| (≤9.59) | (>9.59) | |||
| The primary outcome, n (%) | ||||
| MACE | 66 (9.2) | 17 (3.8) | 49 (18.7) | <0.001 |
| Secondary outcomes, n (%) | ||||
| Cerebrovascular events | 10 (1.4) | 3 (0.7) | 7 (2.7) | <0.001 |
| Hospitalization for heart failure | 13 (1.8) | 4 (0.9) | 9 (3.4) | 0.003 |
| Non-fatal MI | 17 (2.4) | 3 (0.7) | 14 (5.3) | <0.001 |
| Non-cardiac Mortality | 11 (1.5) | 2 (0.4) | 9 (3.4) | <0.001 |
| Cardiac Mortality | 15 (2.1) | 5 (1.1) | 10 (3.8) | 0.002 |
Data are given as numbers (n) and percentages (%). The chi-square test or Fisher’s exact test was performed. * p < 0.05 was considered statistically significant. Abbreviations: MACEs, major adverse cardiovascular events.